Abstract
Verison 2003 of the NCCN Breast Cancer Guideline contains changes reflecting the continued evolution of treatment approaches and the emergency of new agents in the management of invasive breast cancer.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Axilla
-
Biopsy
-
Breast Neoplasms / pathology*
-
Breast Neoplasms / therapy*
-
Carcinoma in Situ / pathology*
-
Carcinoma, Ductal, Breast / pathology*
-
Chemotherapy, Adjuvant
-
Female
-
Hormones / therapeutic use
-
Humans
-
Lymph Nodes / pathology*
-
Neoplasm Staging
-
Practice Guidelines as Topic
-
Radiotherapy, Adjuvant
Substances
-
Antineoplastic Agents
-
Hormones